This Article Abstract Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Exner, D. V. Search for Related Content PubMed PubMed Citation Articles by Exner, D. V.

Beta-blocker use and survival in patients with ventricular fibrillation or symptomatic ventricular tachycardia: the antiarrhythmics versus implantable defibrillators (AVID) trial

Derek V. Exner, MD, MPH^*, James A. Reiffel, MD, FACC, Andrew E. Epstein, MD, FACC, Robert Ledingham, MS, Michael J. Reiter, MD, PhD, FACC, Qing Yao, PhD, Henry J. Duff, MD, Dean Follmann, PhD^*, Eleanor Schron, RN^*, H. Leon Greene, MD, FACC, Mark D. Carlson, MD, FACC, Michael A. Brodsky, MD, FACC, Toshio Akiyama, MD, FACC, Christina Baessler, MSN, Jeffrey L. Anderson, MD, FACC the AVID Investigators^,1

^* National Heart, Lung, and Blood Institute, Bethesda, Maryland, USA
University of Washington, Seattle, Washington, USA
Antiarrythmics Versus Implantable Defribillators (AVID) clinical sites, USA

View larger version (38K): [in a new window]   Figure 1 The 2,901 persons in the present analysis included 970 randomized and 1,931 eligible, nonrandomized patients discharged from hospital with amiodarone alone, an ICD alone or neither of these therapies. Numbers of patients within each treatment strategy are shown in parentheses.